Literature DB >> 36257957

Protein synthesis inhibition and loss of homeostatic functions in astrocytes from an Alzheimer's disease mouse model: a role for ER-mitochondria interaction.

Laura Tapella1, Giulia Dematteis1, Marianna Moro1, Beatrice Pistolato1, Elisa Tonelli1, Virginia Vita Vanella2, Daniele Giustina1, Aleida La Forgia1, Elena Restelli3,4, Elettra Barberis2, Tito Cali5, Marisa Brini6, Salvatore Villani1, Erika Del Grosso1, Mariagrazia Grilli1, Marcello Manfredi2, Marco Corazzari7, Ambra A Grolla1, Armando A Genazzani8, Dmitry Lim9.   

Abstract

Deregulation of protein synthesis and ER stress/unfolded protein response (ER stress/UPR) have been reported in astrocytes. However, the relationships between protein synthesis deregulation and ER stress/UPR, as well as their role in the altered homeostatic support of Alzheimer's disease (AD) astrocytes remain poorly understood. Previously, we reported that in astrocytic cell lines from 3xTg-AD mice (3Tg-iAstro) protein synthesis was impaired and ER-mitochondria distance was reduced. Here we show that impaired protein synthesis in 3Tg-iAstro is associated with an increase of p-eIF2α and downregulation of GADD34. Although mRNA levels of ER stress/UPR markers were increased two-three-fold, we found neither activation of PERK nor downstream induction of ATF4 protein. Strikingly, the overexpression of a synthetic ER-mitochondrial linker (EML) resulted in a reduced protein synthesis and augmented p-eIF2α without any effect on ER stress/UPR marker genes. In vivo, in hippocampi of 3xTg-AD mice, reduced protein synthesis, increased p-eIF2α and downregulated GADD34 protein were found, while no increase of p-PERK or ATF4 proteins was observed, suggesting that in AD astrocytes, both in vitro and in vivo, phosphorylation of eIF2α and impairment of protein synthesis are PERK-independent. Next, we investigated the ability of 3xTg-AD astrocytes to support metabolism and function of other cells of the central nervous system. Astrocyte-conditioned medium (ACM) from 3Tg-iAstro cells significantly reduced protein synthesis rate in primary hippocampal neurons. When added as a part of pericyte/endothelial cell (EC)/astrocyte 3D co-culture, 3Tg-iAstro, but not WT-iAstro, severely impaired formation and ramification of tubules, the effect, replicated by EML overexpression in WT-iAstro cells. Finally, a chemical chaperone 4-phenylbutyric acid (4-PBA) rescued protein synthesis, p-eIF2α levels in 3Tg-iAstro cells and tubulogenesis in pericyte/EC/3Tg-iAstro co-culture. Collectively, our results suggest that a PERK-independent, p-eIF2α-associated impairment of protein synthesis compromises astrocytic homeostatic functions, and this may be caused by the altered ER-mitochondria interaction.
© 2022. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36257957      PMCID: PMC9579125          DOI: 10.1038/s41419-022-05324-4

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   9.685


  79 in total

1.  Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes.

Authors:  Umut Ozcan; Erkan Yilmaz; Lale Ozcan; Masato Furuhashi; Eric Vaillancourt; Ross O Smith; Cem Z Görgün; Gökhan S Hotamisligil
Journal:  Science       Date:  2006-08-25       Impact factor: 47.728

2.  Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC.

Authors:  Hakan Kucukdereli; Nicola J Allen; Anthony T Lee; Ava Feng; M Ilcim Ozlu; Laura M Conatser; Chandrani Chakraborty; Gail Workman; Matthew Weaver; E Helene Sage; Ben A Barres; Cagla Eroglu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-25       Impact factor: 11.205

3.  Phenylbutyrate is a multifaceted drug that exerts neuroprotective effects and reverses the Alzheimer´s disease-like phenotype of a commonly used mouse model.

Authors:  Mar Cuadrado-Tejedor; Ana L Ricobaraza; Rosana Torrijo; Rafael Franco; Ana Garcia-Osta
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 4.  Calcium signalling toolkits in astrocytes and spatio-temporal progression of Alzheimer's disease.

Authors:  Dmitry Lim; J J Rodríguez-Arellano; Vladimir Parpura; Robert Zorec; Fares Zeidán-Chuliá; Armando A Genazzani; Alexei Verkhratsky
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

5.  Inhibition of ER stress attenuates kidney injury and apoptosis induced by 3-MCPD via regulating mitochondrial fission/fusion and Ca2+ homeostasis.

Authors:  Yujie Zhong; Chengni Jin; Jiahui Han; Jiachang Zhu; Qi Liu; Dianjun Sun; Xiaodong Xia; Xiaoli Peng
Journal:  Cell Biol Toxicol       Date:  2021-03-02       Impact factor: 6.691

6.  Ribosome dysfunction is an early event in Alzheimer's disease.

Authors:  Qunxing Ding; William R Markesbery; Qinghua Chen; Feng Li; Jeffrey N Keller
Journal:  J Neurosci       Date:  2005-10-05       Impact factor: 6.709

7.  Thrombospondin receptor α2δ-1 promotes synaptogenesis and spinogenesis via postsynaptic Rac1.

Authors:  W Christopher Risher; Namsoo Kim; Sehwon Koh; Ji-Eun Choi; Petar Mitev; Erin F Spence; Louis-Jan Pilaz; Dongqing Wang; Guoping Feng; Debra L Silver; Scott H Soderling; Henry H Yin; Cagla Eroglu
Journal:  J Cell Biol       Date:  2018-07-27       Impact factor: 10.539

8.  Calcineurin Controls Cellular Prion Protein Expression in Mouse Astrocytes.

Authors:  Giulia Dematteis; Elena Restelli; Virginia Vita Vanella; Marcello Manfredi; Emilio Marengo; Marco Corazzari; Armando A Genazzani; Roberto Chiesa; Dmitry Lim; Laura Tapella
Journal:  Cells       Date:  2022-02-10       Impact factor: 6.600

9.  An expanded palette of improved SPLICS reporters detects multiple organelle contacts in vitro and in vivo.

Authors:  Francesca Vallese; Cristina Catoni; Domenico Cieri; Lucia Barazzuol; Omar Ramirez; Valentina Calore; Massimo Bonora; Flavia Giamogante; Paolo Pinton; Marisa Brini; Tito Calì
Journal:  Nat Commun       Date:  2020-11-27       Impact factor: 14.919

10.  Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer's Disease.

Authors:  Heather Buchanan; Murray Mackay; Kerri Palmer; Karolína Tothová; Miroslava Katsur; Bettina Platt; David J Koss
Journal:  Mol Neurobiol       Date:  2020-06-08       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.